GJA1 and central nervous system cancer: This finding is supported by observations made by Yu and colleagues [23], who identified the expression of Cx43 in moredifferentiated and GJIC-competent human glioma cells, while glioma stem cells wereGJIC-incompetent and Cx43 negative.